Details for Patent: 11,771,841

Which drugs does patent 11,771,841 protect, and when does it expire?

Patent 11,771,841 protects ELIGARD KIT and FENSOLVI KIT and is included in five NDAs.

This patent has thirty patent family members in twenty-five countries.

Summary for Patent: 11,771,841

Title:	Systems and methods for mixing syringe valve assemblies
Abstract:	A syringe mixing system is provided for housing and mixing contents between at least two syringes. In some embodiments, a syringe coupler is provided that receives first and second syringes and includes a valve member that is convertible between a closed position and an open position. Retention systems for preventing or inhibiting removal of at least one syringe after use are also provided.
Inventor(s):	James Sherman, Casey Dean, Carl Hart, John Bingham, Hossam Aboudagher
Assignee:	Tolmar International Ltd
Application Number:	US17/854,769
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound; Device;

Drugs Protected by US Patent 11,771,841

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021343-001	Jan 23, 2002		RX	Yes	Yes	11,771,841		Y	Y
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021379-001	Jul 24, 2002		RX	Yes	Yes	11,771,841		Y	Y
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021488-001	Feb 13, 2003		RX	Yes	Yes	11,771,841		Y	Y
Tolmar	ELIGARD KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	021731-001	Dec 14, 2004		RX	Yes	Yes	11,771,841		Y	Y
Tolmar	FENSOLVI KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	213150-001	May 1, 2020		RX	Yes	Yes	11,771,841		Y	Y

International Family Members for US Patent 11,771,841

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	124487
Australia	2021405417
Canada	3205655
China	116847900
Colombia	2023009588
Denmark	4135830